Vaccines and Immunoinformatics for Vaccine Design

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2022 May 20

PMID 35594022

Authors

Shikha Joon

Rajeev K Singla

Bairong Shen

Affiliations

Soon will be listed here.

Abstract

The host immune system recognizes and responds to the selective antigens or epitopes (immunome) of the intruding pathogen over an entire organism. The immune response so generated is ample to confer the desired immunity and protection to the host. This led to the conception of immunome-derived vaccines that exploit selective genome-derived antigens or epitopes from the pathogen's immunome and not its entire genome or proteome. These are designed to elicit the required immune response and confer protection against future invasions by the same pathogen. Immunoinformatics through its epitope mapping tools allows direct selection of antigens from a pathogen's genome or proteome, which is critical for the generation of an effective vaccine. This paved way for novel vaccine design strategies based on the mapped epitopes for translational applications that includes prophylactic, therapeutic, and personalized vaccines. In this chapter, various Immunoinformatics tools for epitope mapping are presented along with their applications. The methodology for immunoinformatics-assisted vaccine design is also outlined.

Citing Articles

Designing of a multiepitope-based vaccine against echinococcosis utilizing the potent Ag5 antigen: Immunoinformatics and simulation approaches.

Parvin R, Masum M, Heema H, Akter A, Hossain M, Siddiki A PLoS One. 2025; 20(2):e0310510.

PMID: 39937717 PMC: 11819600. DOI: 10.1371/journal.pone.0310510.

Designing of an mRNA vaccine against high-risk human papillomavirus targeting the E6 and E7 oncoproteins exploiting immunoinformatics and dynamic simulation.

Rahman M, Masum M, Parvin R, Das S, Talukder A PLoS One. 2025; 20(1):e0313559.

PMID: 39761277 PMC: 11703113. DOI: 10.1371/journal.pone.0313559.

Design of a novel multi-epitope vaccine candidate against using advanced immunoinformatics approaches: An in silico study.

Saadh M, Ahmed H, Kareem R, Baldaniya L, Verma L, Prasad G Biochem Biophys Rep. 2024; 40:101871.

PMID: 39634337 PMC: 11616549. DOI: 10.1016/j.bbrep.2024.101871.

Designing of a chimeric multiepitope vaccine against bancroftian lymphatic filariasis through immunoinformatics approaches.

Parvin R, Masum M, Ferdous J, Mahdeen A, Khan M PLoS One. 2024; 19(9):e0310398.

PMID: 39298468 PMC: 11412548. DOI: 10.1371/journal.pone.0310398.

A New Strategy for Mapping Epitopes of LACK and PEPCK Proteins of Specific for Major Histocompatibility Complex Class I.

Ferreira-Sena E, Hardoim D, Cardoso F, dEscoffier L, Soares I, Carvalho J Int J Mol Sci. 2023; 24(6).

PMID: 36983046 PMC: 10054446. DOI: 10.3390/ijms24065972.

References

Terry F, Moise L, Martin R, Torres M, Pilotte N, Williams S . Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases. Expert Rev Vaccines. 2014; 14(1):21-35. PMC: 4743591. DOI: 10.1586/14760584.2015.955478. View

Poland G, Whitaker J, Poland C, Ovsyannikova I, Kennedy R . Vaccinology in the third millennium: scientific and social challenges. Curr Opin Virol. 2016; 17:116-125. PMC: 4902778. DOI: 10.1016/j.coviro.2016.03.003. View

Servin-Blanco R, Zamora-Alvarado R, Gevorkian G, Manoutcharian K . Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets. Hum Vaccin Immunother. 2016; 12(10):2640-2648. PMC: 5085008. DOI: 10.1080/21645515.2016.1191718. View

De Groot A, Martin W . From immunome to vaccine: epitope mapping and vaccine design tools. Novartis Found Symp. 2004; 254:57-72. View

Doytchinova I, Taylor P, Flower D . Proteomics in Vaccinology and Immunobiology: An Informatics Perspective of the Immunone. J Biomed Biotechnol. 2003; 2003(5):267-290. PMC: 521502. DOI: 10.1155/S1110724303209232. View

Jongeneel V . Towards a cancer immunome database. Cancer Immun. 2003; 1:3. View

Klade C . Proteomics approaches towards antigen discovery and vaccine development. Curr Opin Mol Ther. 2002; 4(3):216-23. View

Pederson T . The immunome. Mol Immunol. 2000; 36(15-16):1127-8. DOI: 10.1016/s0161-5890(99)00125-x. View

Petrovsky N, Brusic V . Computational immunology: The coming of age. Immunol Cell Biol. 2002; 80(3):248-54. DOI: 10.1046/j.1440-1711.2002.01093.x. View

10.

Rappuoli R . Reverse vaccinology, a genome-based approach to vaccine development. Vaccine. 2001; 19(17-19):2688-91. DOI: 10.1016/s0264-410x(00)00554-5. View

11.

Etz H, Bui Minh D, Henics T, Dryla A, Winkler B, Triska C . Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc Natl Acad Sci U S A. 2002; 99(10):6573-8. PMC: 124444. DOI: 10.1073/pnas.092569199. View

12.

Weichhart T, Horky M, Sollner J, Gangl S, Henics T, Nagy E . Functional selection of vaccine candidate peptides from Staphylococcus aureus whole-genome expression libraries in vitro. Infect Immun. 2003; 71(8):4633-41. PMC: 166000. DOI: 10.1128/IAI.71.8.4633-4641.2003. View

13.

Adamou J, Heinrichs J, Erwin A, Walsh W, Gayle T, Dormitzer M . Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect Immun. 2001; 69(2):949-58. PMC: 97974. DOI: 10.1128/IAI.69.2.949-958.2001. View

14.

Tettelin H, Masignani V, Cieslewicz M, Eisen J, Peterson S, Wessels M . Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci U S A. 2002; 99(19):12391-6. PMC: 129455. DOI: 10.1073/pnas.182380799. View

15.

Ross B, Czajkowski L, Hocking D, Margetts M, Webb E, Rothel L . Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. Vaccine. 2001; 19(30):4135-42. DOI: 10.1016/s0264-410x(01)00173-6. View

16.

Montigiani S, Falugi F, Scarselli M, Finco O, Petracca R, Galli G . Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect Immun. 2001; 70(1):368-79. PMC: 127649. DOI: 10.1128/IAI.70.1.368-379.2002. View

17.

Mathiassen S, Lauemoller S, Ruhwald M, Claesson M, Buus S . Tumor-associated antigens identified by mRNA expression profiling induce protective anti-tumor immunity. Eur J Immunol. 2001; 31(4):1239-46. DOI: 10.1002/1521-4141(200104)31:4<1239::aid-immu1239>3.0.co;2-c. View

18.

Robinson W, Garren H, Utz P, Steinman L . Millennium Award. Proteomics for the development of DNA tolerizing vaccines to treat autoimmune disease. Clin Immunol. 2002; 103(1):7-12. DOI: 10.1006/clim.2002.5185. View

19.

De Groot A . Immunome-derived vaccines. Expert Opin Biol Ther. 2004; 4(6):767-72. DOI: 10.1517/14712598.4.6.767. View

20.

Ortutay C, Vihinen M . Immunome knowledge base (IKB): an integrated service for immunome research. BMC Immunol. 2009; 10:3. PMC: 2632617. DOI: 10.1186/1471-2172-10-3. View